129 related articles for article (PubMed ID: 33582397)
1. Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies.
Drača D; Edeler D; Saoud M; Dojčinović B; Dunđerović D; Đmura G; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2021 Apr; 217():111383. PubMed ID: 33582397
[TBL] [Abstract][Full Text] [Related]
2. Delivery of [Ru(η
Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
[TBL] [Abstract][Full Text] [Related]
3. Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity.
Chao WW; Cheng YW; Chen YR; Lee SH; Chiou CY; Shyur LF
Phytomedicine; 2019 Mar; 56():194-206. PubMed ID: 30668340
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph
Bensing C; Mojić M; Gómez-Ruiz S; Carralero S; Dojčinović B; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Dalton Trans; 2016 Dec; 45(47):18984-18993. PubMed ID: 27847952
[TBL] [Abstract][Full Text] [Related]
5. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K
J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238
[TBL] [Abstract][Full Text] [Related]
6. Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo.
Clemente N; Miletto I; Gianotti E; Invernizzi M; Marchese L; Dianzani U; Renò F
J Photochem Photobiol B; 2019 Aug; 197():111533. PubMed ID: 31254952
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
[TBL] [Abstract][Full Text] [Related]
8. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
[TBL] [Abstract][Full Text] [Related]
9. Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.
Zhao P; Qiu L; Zhou S; Li L; Qian Z; Zhang H
Int J Nanomedicine; 2021; 16():2107-2121. PubMed ID: 33737808
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with TiO
Adibzadeh R; Golhin MS; Sari S; Mohammadpour H; Kheirbakhsh R; Muhammadnejad A; Amanpour S; Moosavi MA; Rahmati M
Clin Transl Oncol; 2021 Apr; 23(4):738-749. PubMed ID: 32734535
[TBL] [Abstract][Full Text] [Related]
11. Effect of chain length on the cytotoxic activity of (alkyl-ω-ol)triphenyltin(IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl|Ph
Bensing C; Mojić M; Bulatović M; Edeler D; Pérez-Quintanilla D; Gómez-Ruiz S; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Biomater Adv; 2022 Sep; 140():213054. PubMed ID: 35964389
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide- and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancer.
Munaweera I; Shi Y; Koneru B; Patel A; Dang MH; Di Pasqua AJ; Balkus KJ
J Inorg Biochem; 2015 Dec; 153():23-31. PubMed ID: 26402659
[TBL] [Abstract][Full Text] [Related]
13. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
[TBL] [Abstract][Full Text] [Related]
14. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
[TBL] [Abstract][Full Text] [Related]
15. The interaction between SBA-15 derivative loaded with Ph
Maksimović-Ivanić D; Bulatović M; Edeler D; Bensing C; Golić I; Korać A; Kaluđerović GN; Mijatović S
J Biol Inorg Chem; 2019 Mar; 24(2):223-234. PubMed ID: 30759278
[TBL] [Abstract][Full Text] [Related]
16. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA
Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646
[TBL] [Abstract][Full Text] [Related]
17. Chrysin, a natural and biologically active flavonoid suppresses tumor growth of mouse B16F10 melanoma cells: In vitro and In vivo study.
Sassi A; Maatouk M; El Gueder D; Bzéouich IM; Abdelkefi-Ben Hatira S; Jemni-Yacoub S; Ghedira K; Chekir-Ghedira L
Chem Biol Interact; 2018 Mar; 283():10-19. PubMed ID: 29352974
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-functionalized three-dimensional magnetic SBA-16 for treating breast cancer cells (MCF-7).
Alomari M; Jermy BR; Ravinayagam V; Akhtar S; Almofty SA; Rehman S; Bahmdan H; AbdulAzeez S; Borgio JF
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3079-3086. PubMed ID: 31352799
[TBL] [Abstract][Full Text] [Related]
20. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
